期刊文献+

糖尿病肾病患者AOPP与SOD,GPx,NPT的关系 被引量:3

Advanced oxidation protein products in diabetic nephropathy patients and its relation with superoxide dismutase,glutathione peroxidase,neopterin
下载PDF
导出
摘要 目的:研究糖尿病肾病患者血清蛋白氧化损伤指标晚期蛋白氧化产物(AOPP)的改变及其与超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)及新喋呤(NPT)的关系,探讨蛋白氧化损伤与糖尿病肾病氧化应激状态和慢性炎症状态的关系。方法:糖尿病患者85例,根据尿微量白蛋白排泄率和肌酐水平分为无糖尿病肾病(DM)组、早期糖尿病肾病(DN3)组、临床糖尿病肾病(DN4)组、终末期糖尿病肾病(DN5)组。用W ikto-sarsat介绍的方法改进后分别测定各组的血清AOPP,黄嘌呤氧化酶法测定SOD,[5,5′-二硫代双(2-硝基苯甲酸)](DTNB)显色法测定GPx,ELISA方法测定血清NPT。结果:DN5组患者的血清AOPP[(117.8±64.8)μmol/L]和DN4组的血清AOPP[(80.0±23.0)μmol/L]显著高于DM组[(58.2±17.7)μmol/L](P<0.01)。DN3组血清AOPP[(72.7±17.2)μmol/L]与DM组间无显著差异。血清AOPP与SOD,GPx呈负相关(r分别为-0.217和-0.374,P<0.05),并与NPT呈正相关(r=0.499,P<0.01)。结论:糖尿病肾病患者的血清蛋白氧化较无糖尿病肾病患者增强,并且与糖尿病肾病氧化应激状态和慢性炎症状态有关。 Objective To determine the changes of advanced oxidation protein products (AOPP) in diabetic nephropathy (DN) patients, as well as its relationship with superoxide dismutase (SOD), glutathione peroxidase (GPx) and neopterin (NPT). Methods By the concentration of urinary albumin excretion rate (UAER) and creatinine (Cr), 85 groups as non-DN group (DM), early-staged DN staged DN group(DN5). The concentration of the diabetes mellitus (DM) patients were divided into 4 group ( DN3 ) , significant DN group (DN4) and endserum AOPP was measured by ameliorated method introduced by Wikto-Sarsat, while SOD by Xanthine oxidase test, GPx by [5,5'Dithio-bis (2-Nitrobenzoic aicd) ] ( DTNB ) reaction test and NPT by ELISA. Results AOPP in Group DN5 [(117.8±64.8 )μmol/L] and Group DN4 [(80.0±23.0)μmol/L] were significantly higher than those in Group DM [(58.2±17.7)μmol/L]. There was no significant difference of AOPP between Group DN3 [(72.7±17.2)μmol/L] and Group DM. Serum AOPP negatively correlated with SOD and GPx(r=-0. 217 and -0. 374 respectively,P 〈0.05 ), while positively correlated with NPT ( r=0. 499 ,P 〈0.01 ). Conclusion DN patient has enhanced protein oxidation than DM patient, which is related to oxidative stress and chronic inflammation in DN.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第6期704-707,共4页 Journal of Central South University :Medical Science
基金 广东省重点科技攻关项目(99m04b16g)
关键词 糖尿病肾病 AOPP SOD GPX NPT diabetic nephropathy advanced oxidation protein products superoxide dismutase glutathione peroxidase neopterin
  • 相关文献

参考文献11

  • 1陈秋.氧化应激在糖尿病肾病中的作用[J].重庆医科大学学报,1999,24(3):334-336. 被引量:1
  • 2Kalousova M,Skrha J,Zima T.Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus[J].Physiol Res,2002,51(6):597-604.
  • 3Witko-Sarsat V,Nguyen-Khoa T,Jungers P,et al.Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia[J].Nephrol Dial Transplant,1999,14(Suppl 1):76-78.
  • 4Wolff SP,Dean RT.Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis[J].Biochem J,1986,234(2):399-403.
  • 5Telci A,Cakatay U,Salman S,et al.Oxidative protein damage in early stage Type 1 diabetic patient[J].Diab Res Clin Pract,2000,50(3):213-223.
  • 6Witko-Sarsat V,Friedlander M,Nguyen Khoa T,et al.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure[J].J Immunol,1998,161(5):2524-2532.
  • 7Naskalski JW,Marcinkiewicz J,Drozdz R.Myeloperoxidase-mediated protein oxidation:its possible biological functions[J].Clin Chem Lab Med,2002,40(5):463-468.
  • 8Witko-Sarsat V,Gausson V,Descamps-Latscha B.Are advanced oxidation protein products potential uremic toxins?[J].Kidney Int,2003,84(Suppl):S11-14.
  • 9Mizobuchi N,Nakata H,Horimi T,et al.Serum superoxide dismutase(SOD) activity in diabetes mellitus[J].Rinsho Byori,1993,41(6):673-678.
  • 10Kimura F,Hasegawa G,Obayashi H,et al.Serum extracellular superoxide dismutase in patients with type 2 diabetes:relationship to the development of micro-and macrovascular complications[J].Diabetes Care,2003,26(4):1246-1250.

二级参考文献5

  • 1Jain S K,Metabolism,1994年,43卷,306页
  • 2Yu P H,Diabetes,1993年,42卷,594页
  • 3Fu M X,Diabetes,1992年,41卷,增刊,42页
  • 4Ha H,Yonsei Med J,1992年,33卷,217页
  • 5Ha H,Physiologist,1991年,34卷,249页

同被引文献25

  • 1左岩霞,韩艳丽,王营,王健,姜红菊,刘芳,李继福,纪求尚.不稳定型心绞痛血运重建后氧化和抗氧化指标的动态变化[J].临床心血管病杂志,2004,20(9):515-517. 被引量:3
  • 2杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
  • 3张志辉,刘尚喜,侯凡凡,田建伟,王力,刘志强,陈瑗.晚期氧化蛋白产物通过活性氧诱导单核细胞分泌肿瘤坏死因子[J].第一军医大学学报,2005,25(5):493-497. 被引量:17
  • 4Foley R N,Parfrey P S. Cardiovascular disease and mortality in ESRD[J]. J Nephrol,1998,11:239-245.
  • 5Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen- Khoa T , Nguyen A T, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J]. Kidney Int. ,1996,49:1304-1313.
  • 6Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, Capeillere- Blandin C, Nguyen A T,Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure[J]. J Immunol, 1998,161: 2524-2532.
  • 7Cheung A K,Sarnak M J,Yan G,Berkoben M,Heyka R,Kauf man A,et al. Cardiac diseases in maintenance hemodialysis patients:results of the HEMO study[J]. Kidney Int, 2004, 65 2380-2389.
  • 8Samouilidou E C, Grapsa E J, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis[J]. Int Urol Neph rol, 2003,35 :393-397.
  • 9Witko Sarsat V, Gausson V, Nguyen A T, Touam M, Drueke T,Santangelo F, et al. AOPP-induced activation of human neu trophil and monocyte oxidative metabolism: a potential target for N acetylcysteine treatment in dialysis patients[J]. Kidney Int,2003,64:82-91.
  • 10Man PYW, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet,2002,39 : 162-169.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部